Bilcare Global Clinical Supplies, [www.BilcareGCS.com] the single source provider of quality clinical trial materials spread across Americas, Europe and Asia has appointed Vito Mangiardi, a 30-year Industry veteran as the new CEO.

Speaking on this momentous occasion, Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare Ltd. said, “Vito is an exceptional leader and strategist. He has vast experience in global business management, pharmaceutical and biotech contract research and development services, and extensive expertise in clinical supplies. Vito’s breadth and depth of experience is unsurpassed in the industry and he is a perfect fit for Bilcare GCS as we continue to experience steady growth.”

According to Mangiardi, “This is an honor and tremendous opportunity for me to add value to this booming enterprise.”

Mangiardi has gained a wealth of experience in virtually all aspects of the clinical supplies, pharmaceutical and biotech industries. He has held key leadership positions throughout his career, most recently serving as President of North American Operations for AAI Pharma. At AAI, Mangiardi grew the revenue line dramatically and turned the company results from a loss to a profit within two years.

Prior to his stint at AAI Pharma, Mangiardi had a very successful career at Quintiles Transnational as a Senior Vice President and Chief Operating Officer of Global Phase IV Services. He also held other executive level positions at Quintiles including head of the International Clinical Development Services group in Japan, head of the Asia Pacific Business and Executive Vice President of Operational Services of Quintiles Americas. Mangiardi has also served as President and CEO of Clingenix, Inc., an early stage pharmacogenomics company, and as President and CEO of Diagnostic Laboratories.

The addition of Mangiardi’s expertise in pharmaceutical, biotech and clinical supplies and services is another key element of a major global initiative that Bilcare GCS started in 2007. The initiative was undertaken to allow the company to provide a higher level of quality and service to its customers . During the last several months, the company has made substantial improvements globally including upgrading equipment, increasing the number of its state-of-the-art packaging rooms, expanding its storage and distribution facilities, enhancing its formulation and analytical development services and technical capabilities, and integrating global operations.

Sourced From: Corporate Voice|Weber Shandwick

Tags: calls, daytrading, free calls, intraday, tips

Similar Posts:

• Tata Power appoints Banmali Agrawala as E.D.,
• IndusInd Bank appoints Romesh Sobti as MD & CEO
• HDFC Securities appoints Aseem Dhru as MD & CEO
• CTE appoints Brian Courtney as Senior VP & GM Govt Soln
• CEAT appoints Sunil Sapre as CFO